Archive · 27 Jul 2025
Appetite Drugs: Impact and Societal Implications Questioned
Some new drugs, like Ozempic, help people lose weight by reducing their appetite.
The author thinks they won't change society much because people eat for reasons beyond hunger, such as enjoyment or habit.
He suggests that while these drugs might help some, they won't fix the real reasons why people eat too much.
He worries about people becoming reliant on drugs instead of exercise and potentially facing health problems because their bodies might not get enough nutrients.
Semaglutide and Tirzepatide, originally for diabetes, reduce appetite and lead to weight loss.
The author doubts these drugs will cause a major societal shift due to the complex reasons people eat.
The author argues that the drugs won't address the underlying causes of overeating.
The author believes that the drugs may make already fit individuals fitter.
Potential drawbacks include reliance on drugs over exercise and potential metabolic issues.
- Who
- The author, Manu Joseph, a journalist and novelist, analyzes the implications of weight loss drugs.
- What
- The author discusses the potential impact of appetite-reducing drugs like Semaglutide and Tirzepatide on society and health.
- When
- The article reflects on current societal trends and potential future impacts.
- Where
- The article doesn't mention a specific location, it is a general commentary.
- Why
- The author questions the potential societal and health impacts of appetite-suppressing drugs.
Potential Benefits
Potential Risks
Overall Impact
Potential Benefits
Weight loss and improved health for some individuals.
Potential Risks
Potential for reliance and neglect of exercise.
- Drugs Discussed
- Semaglutide (Ozempic), Tirzepatide (Mounjaro)
- Primary Use
- Diabetes treatment
- Side Effect
- Appetite reduction, weight loss
- Author's View
- Modest impact, potential for misuse